Diabetes Complications Clinical Trial
Official title:
Autologous Bone Marrow Transplant in Chronic Insulin Dependent Diabetic Patients Phase II Clinical Trial. Version: 1.3 - January 13, 2016
Diabetes, recently declared a pandemic by the World Health Organization, is a risk factor for increased mortality and morbidity. Its multi-functional complications, in the short and long term, are a serious problems for the global public health. Millions of patients, the world over, suffer Diabetes, a chronic and degenerative disease without treatments today. America, and particularly the Caribbean and Central America Region, is seriously affected despite the efforts of the Public Health Systems. Caribbean Region presented nearly twice the incidence and prevalence of type 1 and type 2 diabetes when compared with the rest of the Americas. Today stem cells are emerging as a valid alternative of treatment. In vitro experiments with adult stem cells demonstrated their ability to migrate and differentiate into cells of different lineages. The bone marrow stem cells are safe, effective and have a lot of scientific evidence that supports the carrying out of clinical research in phases II and III. Our protocol is an Autologous Bone Marrow Stem Cell Transplantation, without immune suppression or cell cultures. Our hypothesis is that the stem cells will act as immune modulators, angiogenic and in a regenerative way stimulating quiescent stem cells and improving the metabolic control by endogenous secretion of insulin.
Our clinical trial, authorized and controlled by the Government of Bahamas, offer safety data and effectiveness that encourage continued research. We will divide the patients into a treatment group and into a control group. We will control insulin daly dose, c peptide, A1C glycated hemoglobin and specific antibodies. Follow up two years. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT03022721 -
Heidelberg Study on Diabetes and Complications
|
N/A | |
| Withdrawn |
NCT02580266 -
Blood/Urine Markers for Drug Discovery for Renal Disease in Diabetes
|
||
| Completed |
NCT02423434 -
Evaluation of Corneal Confocal Microscopy for the Identification and Prediction of Neuropathy in Type 1 Diabetes
|
||
| Completed |
NCT03426566 -
Abnormal Plantar Pressure in Patients With Diabetes
|
||
| Completed |
NCT01695278 -
A Pilot Intervention Study of Health Coaching to Promote Diabetes Self-Care in the Community
|
Phase 3 | |
| Completed |
NCT02588898 -
B-Vitamins and Polyneuropathy in Patients With Type 2 Diabetes
|
||
| Completed |
NCT00815178 -
Effects of Inspiratory Muscle Training on Type 2 Diabetes Mellitus Patients With Inspiratory Muscle Weakness
|
N/A | |
| Not yet recruiting |
NCT04537676 -
Patient Empowerment Study
|
||
| Terminated |
NCT02915263 -
The Efficacy Of Intravenous Immunoglobulin Therapy In Treatment Induced Neuropathy Of Diabetes
|
Phase 2 | |
| Completed |
NCT01929018 -
Collaborative-care Rehabilitation After Dysvascular Amputation
|
N/A | |
| Completed |
NCT03877523 -
Cocarnit Effects on Macrophages Polarization
|
N/A | |
| Completed |
NCT02928939 -
Therapeutic Conflicts and Multimorbidity
|
||
| Completed |
NCT02947828 -
Polyneuropathy in Diabetes Mellitus Type 2
|
||
| Recruiting |
NCT02275091 -
Children With Diabetes at Risk for Heart Disease.
|
||
| Terminated |
NCT00529204 -
Effects Of Exenatide On Liver Biochemistry, Liver Histology And Lipid Metabolism In Patients With Fatty Liver Disease
|
Phase 2 | |
| Not yet recruiting |
NCT05074849 -
Benefits of Insoles With Real-Time Alert and Foot Self-Care Education
|
N/A | |
| Completed |
NCT04963998 -
Safety and Efficacy Study of MedCu Wound Dressings
|
N/A | |
| Recruiting |
NCT06321029 -
Electronic Diabetes Tune-Up Group (eDTU) for African Americans
|
N/A | |
| Active, not recruiting |
NCT03620773 -
Impact of Metabolic Surgery on Pancreatic, Renal and Cardiovascular Health in Youth With Type 2 Diabetes
|
Phase 1/Phase 2 | |
| Completed |
NCT05231642 -
Individualised Postprandial Glucose Responses in Type 1 Diabetes
|
N/A |